NCT06307249View on ClinicalTrials.gov

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
CancerSolid TumorColorectal CancerBreast CancerOvarian CancerLung CancerTargeted TherapyChemotherapyImmunotherapyPrecision Therapy
Interventions
GENETIC

SNP

Diagnostics of patients' carriers or not of the risk allele(s)

DRUG

Palbociclib 125mg

Palbociclib 125mg/day/os over 21 days every 28 days

DRUG

Bevacizumab

10mg/kg every 21 days

Trial Locations (2)

961

RECRUITING

Haykel Hospital, Tripoli

RECRUITING

Lebanese University, Tripoli

All Listed Sponsors
collaborator

Haykel Hospital

UNKNOWN

lead

Lebanese University

OTHER